Medtronic (MDT) Granted 510(k) Clearance by FDA for LUCAS(TM) 2
Down)
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today that LUCAS(TM) 2, the next-generation LUCAS(TM) Chest Compression System, has been granted 510(k) market clearance by the U.S. FDA. Developed and manufactured by Jolife AB and distributed exclusively in the United States by Physio-Control, the LUCAS 2 is an automated, battery-powered device that is designed to give consistent, uninterrupted compressions to victims in cardiac arrest.
More from the release.
More from the release.
You May Also Be Interested In
- Medtronic Foundation Supports New Initiative to Develop National Plans Addressing Noncommunicable Diseases (NCDS)
- Mylan (MYL) Unit Launches Generic Viramune Tabs
- Chelsea Therapeutics (CHTP) Completes End-of-Review Meeting with FDA Over Northera NDA
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
